bf/NASDAQ:DYN_icon.png

NASDAQ:DYN

Dyne Therapeutics

  • Stock

11.99

+1.70%

0.37

USD last updated 13/08 01:59:42

Last Close

11.62

12/08 20:01

Market Cap

3.87B

Beta: 0.24

Volume Today

1.59M

Avg: 383.32K

PE Ratio

−6.54

PFCF: −7.34

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle dis...Show More

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52019-06-292020-03-312022-03-102024-03-072024-11-04

    Revenue (Estimate*)

    1M2M3M4M2019-06-292020-03-312022-03-102024-03-072024-11-04

    *Estimate based on analyst consensus